Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Negotiation and Competitive Licensing Act of 2019
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Foreign Drug Data Protection Laws ---China Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2019 · second_quarter · Q2
Capital Market Enhancements ---Amended Definition of Smaller Reporting Company Proxy Advisory Services ---Reintroduction of the Corporate Governance Fairness Act in the Senate ---Corporate Governance Reform and Transparency ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---S.452: Fostering Innovation Act of 2019 ---Reintroduction of the Fostering Innovation Act in the House of Representatives ---Small Issuer Exemption Short Selling Transparency
Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Foreign Drug Data Protection Laws ---China Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions
Source: Senate LDA
Medicare Negotiation and Competitive Licensing Act of 2019
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---S. 97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S. 844: Short on Competition Act of 2019 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Japan Biotechnology Regulations ---Korea Biotechnology Regulations ---Like-minded Countries Initiatives Foreign Drug Data Protection Laws ---China Intellectual Property International Enforcement ---Compulsory Licensing ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions Trade and Foreign Drug Price Controls Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation US-UK Trade Agreement ---IP Provisions US-EU Trade Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions World Trade Organization - Special 301 Submissions ---Canada ---China ---India ---Latin America ---Malaysia ---Middle East
Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Foreign Drug Data Protection Laws ---China Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions
Medicare Negotiation and Competitive Licensing Act of 2019
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Foreign Drug Data Protection Laws ---China Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions
Medicare Negotiation and Competitive Licensing Act of 2019
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---S. 97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S. 844: Short on Competition Act of 2019 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Japan Biotechnology Regulations ---Korea Biotechnology Regulations ---Like-minded Countries Initiatives Foreign Drug Data Protection Laws ---China Intellectual Property International Enforcement ---Compulsory Licensing ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions Trade and Foreign Drug Price Controls Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation US-UK Trade Agreement ---IP Provisions US-EU Trade Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions World Trade Organization - Special 301 Submissions ---Canada ---China ---India ---Latin America ---Malaysia ---Middle East
Fostering Innovation Act of 2019
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---Amended Definition of Smaller Reporting Company Proxy Advisory Services ---Reintroduction of the Corporate Governance Fairness Act in the Senate ---Corporate Governance Reform and Transparency ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---S.452: Fostering Innovation Act of 2019 ---Reintroduction of the Fostering Innovation Act in the House of Representatives ---Small Issuer Exemption Short Selling Transparency
Fostering Innovation Act of 2019
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Corporate Governance Reform and Transparency ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---Reintroduction of the Fostering Innovation Act in the House of Representatives ---S.452: Fostering Innovation Act of 2019 ---Small Issuer Exemption Short Selling Transparency
Small Business Cyber Training Act of 2019
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Foreign Drug Data Protection Laws ---China Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions
Short on Competition Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---S. 97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S. 844: Short on Competition Act of 2019 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Japan Biotechnology Regulations ---Korea Biotechnology Regulations ---Like-minded Countries Initiatives Foreign Drug Data Protection Laws ---China Intellectual Property International Enforcement ---Compulsory Licensing ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions Trade and Foreign Drug Price Controls Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation US-UK Trade Agreement ---IP Provisions US-EU Trade Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions World Trade Organization - Special 301 Submissions ---Canada ---China ---India ---Latin America ---Malaysia ---Middle East
Short on Competition Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Foreign Drug Data Protection Laws ---China Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions
Affordable and Safe Prescription Drug Importation Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Foreign Drug Data Protection Laws ---China Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions
Affordable and Safe Prescription Drug Importation Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---S. 97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S. 844: Short on Competition Act of 2019 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Japan Biotechnology Regulations ---Korea Biotechnology Regulations ---Like-minded Countries Initiatives Foreign Drug Data Protection Laws ---China Intellectual Property International Enforcement ---Compulsory Licensing ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions Trade and Foreign Drug Price Controls Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation US-UK Trade Agreement ---IP Provisions US-EU Trade Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions World Trade Organization - Special 301 Submissions ---Canada ---China ---India ---Latin America ---Malaysia ---Middle East
Financial CHOICE Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Financial CHOICE Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
Fostering Innovation Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Fostering Innovation Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
Small Business Innovation Protection Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Small Business Innovation Protection Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
TRID Improvement Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
TRID Improvement Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Corporate Governance Reform and Transparency Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
Corporate Governance Reform and Transparency Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Small Company Disclosure Simplification Act of 2018
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Fostering Innovation Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
Fostering Innovation Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Corporate Governance Fairness Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
JOBS and Investor Confidence Act of 2018
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
JOBS and Investor Confidence Act of 2018
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Small Business Innovation Protection Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Small Business Innovation Protection Act of 2017
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2019 · first_quarter · Q1
Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---S. 97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S. 844: Short on Competition Act of 2019 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Japan Biotechnology Regulations ---Korea Biotechnology Regulations ---Like-minded Countries Initiatives Foreign Drug Data Protection Laws ---China Intellectual Property International Enforcement ---Compulsory Licensing ---China ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions Trade and Foreign Drug Price Controls Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation US-UK Trade Agreement ---IP Provisions US-EU Trade Agreement ---IP Provisions ---Ag-Biotech Provisions US-Japan Trade Agreement ---IP Provisions World Trade Organization - Special 301 Submissions ---Canada ---China ---India ---Latin America ---Malaysia ---Middle East
Proxy Advisory Services ---Corporate Governance Reform and Transparency ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---Reintroduction of the Fostering Innovation Act in the House of Representatives ---S.452: Fostering Innovation Act of 2019 ---Small Issuer Exemption Short Selling Transparency
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2018 · fourth_quarter · Q4
Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2018 · third_quarter · Q3
Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office